共推医药创新与成果转化，鲁南制药与南方医科大学达成战略合作

Group 1 - The core viewpoint of the article highlights the strategic collaboration between Lunan Pharmaceutical Group and Southern Medical University, focusing on the development of new drugs, high-end formulations, and innovative biopharmaceuticals to facilitate the transition of original research from the laboratory to clinical and industrial applications [1][3] Group 2 - Southern Medical University emphasizes that this collaboration is a significant step in expanding university-enterprise partnerships and promoting coordinated development in the pharmaceutical and health sectors [3] - Both parties aim to establish a regular communication mechanism and refine cooperation pathways to deepen collaboration in technological innovation and the transformation of research outcomes [3] - Lunan Pharmaceutical Group outlines its development history, industry layout, and innovation achievements, suggesting that both parties should explore potential directions for collaboration in service of the "Healthy China" initiative, particularly in building research innovation and outcome transformation platforms [3] - The collaboration may involve creating experimental platforms and jointly training innovative talents, aiming for a deep integration of the education chain, talent chain, industry chain, and innovation chain to enhance public health services and contribute to the revitalization of traditional Chinese medicine and high-quality development of the pharmaceutical industry [3]